These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 15384001)

  • 1. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Hammerer P
    Aktuelle Urol; 2004 Sep; 35(5):371-2. PubMed ID: 15384001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Ohlmann C; Heidenreich A
    Aktuelle Urol; 2004 Sep; 35(5):372-4. PubMed ID: 15478268
    [No Abstract]   [Full Text] [Related]  

  • 3. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of bicalutamide in adjuvant treatment of prostatic carcinoma after primary therapy with curative aim. The viewpoint of the surgeon].
    Rigatti P; Scattoni V
    Recenti Prog Med; 2002 Mar; 93(3):183-5. PubMed ID: 11942171
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant hormone therapy in prostatic cancer: after treatment with curative intent. The viewpoint of the urologist].
    Martorana G
    Recenti Prog Med; 2002 Mar; 93(3):179-82. PubMed ID: 11942170
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant chemotherapy and/or hormone therapy after radical prostatectomy for high-risk prostate cancer].
    Paule B; de la Taille A
    Prog Urol; 2005 Apr; 15(2):208-12. PubMed ID: 15999594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results].
    Peneau M; Piéchaud T; Cariou G; Ragni E; Fontaine E; Fournier G
    Prog Urol; 1998 Dec; 8(6):977-93. PubMed ID: 9894256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer.
    Bottke D; de Reijke TM; Bartkowiak D; Wiegel T
    Eur J Cancer; 2009 Sep; 45 Suppl 1():148-57. PubMed ID: 19775613
    [No Abstract]   [Full Text] [Related]  

  • 10. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
    Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
    J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors.
    Brooks JP; Albert PS; Wilder RB; Gant DA; McLeod DG; Poggi MM
    J Urol; 2005 Dec; 174(6):2204-8, discussion 2208. PubMed ID: 16280764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
    J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: non-metastatic.
    Wilt T
    Clin Evid; 2002 Jun; (7):812-23. PubMed ID: 12230707
    [No Abstract]   [Full Text] [Related]  

  • 14. Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.
    Lotan Y
    Eur Urol; 2007 Aug; 52(2):453-4. PubMed ID: 17674436
    [No Abstract]   [Full Text] [Related]  

  • 15. [PSA and follow-up after treatment of prostate cancer].
    Benchikh El Fegoun A; Villers A; Moreau JL; Richaud P; Rebillard X; Beuzeboc P
    Prog Urol; 2008 Mar; 18(3):137-44. PubMed ID: 18472065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment option for pT3 patient after radical prostatectomy].
    Sugimura Y; Wakita T; Mizogam A
    Hinyokika Kiyo; 2005 Sep; 51(9):571-3. PubMed ID: 16229368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant and salvage radiotherapy after radical prostatectomy].
    Milecki P; Kwias Z; Skowronek J; Stachowski T
    Pol Merkur Lekarski; 2004 May; 16(95):495-9. PubMed ID: 15518437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary results of radical surgery and radiotherapy of locally advanced prostate cancer (basal PSA >50 ng/ml)].
    Kaprin AD; Khmelevskiĭ EV; Fadeev AV
    Vopr Onkol; 2007; 53(4):479-81. PubMed ID: 17969415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer: immediate postoperative or salvage?].
    Pasquier D; Kouto H; Ballereau C
    Prog Urol; 2009 Jul; 19(7):447-56. PubMed ID: 19559374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.